National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
lexatumumab (lek-suh-TOO-moo-mab)

 A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Lexatumumab binds to a protein on the surface of tumor cells, which causes them to die.

Previous Definitions:levofloxacin, levonorgestrel, Levulan, Levulan Kerastick, Lexapro
Next Definitions:LGD1069, LH-RH, LH-RH agonist, Lhermitte's sign, Li-Fraumeni syndrome